GALLI, GIULIA
GALLI, GIULIA
Dipartimento di Oncologia ed Emato-Oncologia
Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference Center
2020 G. Galli, A. Trama, L. Abate-Daga, M. Brambilla, M. Chiara Garassino, A. Fabbri
Association between Antibiotic-Immunotherapy Exposure Ratio and outcome in metastatic Non Small Cell Lung Cancer
2019 G. Galli, T. Triulzi, C. Proto, D. Signorelli, M. Imbimbo, M. Poggi, G. Fucà, M. Ganzinelli, M. Vitali, D. Palmieri, A. Tessari, F. de Braud, M. Garassino, M. Colombo, G. Lo Russo
Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer
2016 A. Gevorgyan, G. Bregni, G. Galli, M. Ganzinelli, A. Martinetti, S.L. Vullo, L. Mariani, F. Festinese, E. Sottotetti, F. De Braud, S. Di Cosimo
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019 C. Proto, R. Ferrara, D. Signorelli, G. Lo Russo, G. Galli, M. Imbimbo, A. Prelaj, N. Zilembo, M. Ganzinelli, L. Pallavicini, I. De Simone, M. Colombo, A. Sicad, V. Torri, M. Garassino
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
2022 G. Galli, P.A. Corsetto, C. Proto, G. Lo Russo, M. Ganzinelli, E. Rulli, L. Legramandi, D. Morelli, R. Ferrara, A. Prelaj, D. Signorelli, A. De Toma, M. Brambilla, M. Occhipinti, S. Manglaviti, M. Boeri, A. Martinetti, A. Vingiani, M.P. Colombo, A.M. Rizzo, V. Torri, F. de Braud, S. Sangaletti, A. Sica, M.C. Garassino
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2018 S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
2019 G. Galli, S. Cavalieri, L. Di Guardo, C. Cimminiello, F. Nichetti, F. Corti, M. Garcia, B. Pappalardi, C. Fallai, F. de Braud, M. Platania, M. Del Vecchio
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional study
2017 G. Galli, A. Tessari, L. Porcu, G. Bregni, B. Paolini, M.L. Carcangiu, M. Gennaro, M.C. De Santis, L. Lozza, F. de Braud, S. Di Cosimo
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapies
2015 D. Serpico, L. Porcu, A. Tessari, A. Gevorgyan, G. Bregni, G. Galli, F. de Braud, V. Torri, S. Di Cosimo
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
2019 G. Galli, A. De Toma, F. Pagani, G. Randon, B. Trevisan, A. Prelaj, R. Ferrara, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, F. de Braud, M. Garassino, G. Lo Russo
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial
2019 C. Vernieri, D. Signorelli, G. Galli, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, G. Vandoni, C. Gavazzi, T. Triulzi, M.P. Colombo, A.M. Rizzo, P.A. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
2016 A. Gevorgyan, G. Bregni, G. Galli, E. Zanardi, F. De Braud, S. Di Cosimo
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
2018 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, M. Vitali, M. Ganzinelli, C. Lanti, G. Molino, F. Stangoni, N. Zilembo, F. de Braud, M. Garassino, D. Signorelli
Metformin plus /- cyclic fasting mimicking diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma : The FAME trial
2019 G. Galli, D. Signorelli, C. Vernieri, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, C. Gavazzi, A.M. Rizzo, P. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
2018 G. Lo Russo, A. Tessari, M. Capece, G. Galli, F. de Braud, M.C. Garassino, D. Palmieri
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, R. Ferrara, N. Zilembo, M. Ganzinelli, A. Sica, V. Torri, M. Colombo, C. Vernieri, A. Balsari, F. de Braud, M. Garassino, D. Signorelli
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer
2017 G. Galli, G. Bregni, S. Cavalieri, L. Porcu, P. Baili, A. Hade, F. Di Salvo, M. Sant, R. Agresti, M. Gennaro, S. Folli, M.C. De Santis, B. Paolini, M.L. Carcangiu, F. De Braud, S. Di Cosimo
Patient preferences for lung cancer treatments : A study protocol for a preference survey using discrete choice experiment and swing weighting
2021 D. Monzani, S. Petrocchi, S. Oliveri, J. Veldwijk, R. Janssens, L. Bailo, M.Y. Smith, I. Smith, E. Schoefs, K. Nackaerts, M. Vandevelde, E. Louis, H. Decaluwé, P. De Leyn, H. Declerck, E.G. Katz, F. Petrella, M. Casiraghi, I. Durosini, G. Galli, M.C. Garassino, G.A. de Wit, G. Pravettoni, I. Huys
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study
2019 G. Mariani, G. Galli, S. Cavalieri, P. Valagussa, G. Bianchi, G. Capri, S. Cresta, L. Ferrari, S. Damian, M. Duca, F. de Braud, A. Moliterni
THE EUDRACT 2017-004494-13 TRIAL ON THYMIC EPITHELIAL TUMORS: THE PARADIGM OF A COMPREHENSIVE STUDY FOR A RARE DISEASE
2022 G. Galli